Next Article in Journal
Management of Aromatase Inhibitor–Induced Arthralgia
Previous Article in Journal
Microrna Let-7: An Emerging Next-Generation Cancer Therapeutic
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Article

Management of Hot Flashes in Women with Breast Cancer

Supportive Care, London Regional Cancer Program, London, ON N6A 4L6, Canada
*
Author to whom correspondence should be addressed.
Received: 7 November 2009 / Revised: 11 December 2009 / Accepted: 5 January 2010 / Published: 1 February 2010
Hormone-suppression therapies are used for the treatment of breast cancer in the adjuvant and metastatic settings alike. However, side effects—including hot flashes—are frequently reported by patients as a cause of therapy discontinuation. This paper presents an overview of hormonal therapies and the evidence-based management options for hot flashes, summarized in a treatment algorithm.
Keywords: breast cancer; hot flashes; tamoxifen; aromatase inhibitors breast cancer; hot flashes; tamoxifen; aromatase inhibitors
MDPI and ACS Style

Kligman, L.; Younus, J. Management of Hot Flashes in Women with Breast Cancer. Curr. Oncol. 2010, 17, 81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473

AMA Style

Kligman L, Younus J. Management of Hot Flashes in Women with Breast Cancer. Current Oncology. 2010; 17(1):81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473

Chicago/Turabian Style

Kligman, L., and J. Younus 2010. "Management of Hot Flashes in Women with Breast Cancer" Current Oncology 17, no. 1: 81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop